AbCellera Biologics Inc logo

AbCellera Biologics Inc (8QQ)

Market Open
3 Nov, 20:00
4. 75
+0.16
+3.58%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.47 Eps
4.58
Previous Close
Day Range
4.75 4.75
Year Range
1.69 5.58
Want to track 8QQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 4 days
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
11 Nov 2025 (In 4 days)
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
6 Nov 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
3 Nov 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
12 Aug 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
5 May 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
18 Feb 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
31 Oct 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
1 Aug 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
13 Jun 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
20 Feb 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc logo
ABCL AbCellera Biologics Inc
2 Nov 2023
-
Cons. EPS
-
EPS

8QQ Earnings Reports FAQ

What is the earnings per share (EPS) for 8QQ?

The current EPS is -0.47.

What is the company's earnings growth rate?

AbCellera Biologics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

AbCellera Biologics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for AbCellera Biologics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 8QQ at this time, as AbCellera Biologics Inc has no recent EPS data to calculate it.